FAKTOR-OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 06:00:04 2024-05-10 EDT | ||
| 4.93 EUR | -0.20% |
|
| Current month | -14.38% | ||
| 1 month | -14.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 4.93 | -0.20% | 0 |
| 24-05-09 | 4.94 | -2.95% | 0 |
| 24-05-08 | 5.09 | -1.36% | 0 |
| 24-05-07 | 5.16 | -0.39% | 0 |
| 24-05-06 | 5.18 | +3.60% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 06:00 am
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0Q0F |
| ISIN | DE000SB0Q0F5 |
| Date issued | 2020-06-04 |
| Strike | 223.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.97 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.09 € |
|---|---|
| Lowest since issue | 4.81 € |
| Spread | 0.02 € |
| Spread % | 0.40% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.9
USD
Average target price
313.3
USD
Spread / Average Target
+0.14%
- Stock Market
- Certificates
- Certificat